Global Implantable Ports Market, By Type (Single Lumen, Double Lumen, and Power-Injectable), Material (Polyurethane, Silicone, Titanium, and Others), Application (Chemotherapy, Blood Transfusion, Antibiotics, Intravenous Infusion of Blood Product, Pain Management, and Others), End Users (Hospitals, Clinics, Ambulatory Surgical Centre, Dialysis Centers, and Others) - Industry Trends and Forecast to 2030.
Implantable Ports Market Analysis and Insights
The increasing prevalence of chronic diseases and the growing demand for minimally invasive procedures are expected to drive market growth. The rising healthcare expenditure for better healthcare services is also attributed to market growth. The major market players are highly focused on product launches during the period. In addition, the government and regulatory bodies are supporting market players with product approval due to emergence. The market is growing in the forecast year due to the high demand for precision medicine and targeted therapy. However, stringent requirements for approval are expected to restrain market growth.
Data Bridge Market Research analyzes that the global implantable ports Market is expected to grow at a CAGR of 7.8% during the forecast period of 2023 to 2030.
|
Report Metric
|
Details
|
|
Forecast Period
|
2023 to 2030
|
|
Base Year
|
2022
|
|
Historic Year
|
2021 (Customizable to 2015-2020)
|
|
Quantitative Units
|
Revenue in Thousand, Pricing in USD
|
|
Segments Covered
|
By Type (Single Lumen, Double Lumen, and Power-Injectable), Material (Polyurethane, Silicone, Titanium, and Others), Application (Chemotherapy, Blood Transfusion, Antibiotics, Intravenous Infusion of Blood Product, Pain Management, and Others), End Users (Hospitals, Clinics, Ambulatory Surgical Centre, Dialysis Centers, and Others)
|
|
Countries Covered
|
U.S., Canada, Mexico, Germany, U.K., France, Italy, Russia, Spain, Netherlands, Switzerland, Belgium, Turkey, Rest of Europe, China, Japan, India, Australia & New Zealand, South Korea, Indonesia, Philippines, Thailand, Malaysia, Singapore, Rest of Asia Pacific, South Africa, Egypt, Saudi Arabia, U.A.E., Israel, Rest of Middle East and Africa, Brazil, Argentina, and Rest of South America
|
|
Market Players Covered
|
B. Braun SE, AngioDynamics, BD, Teleflex Incorporated, Vygon, ICU Medical, Inc., Districlass Médical, AMI GmbH, and PakuMedmedical products gmbh among others
|
Market Definition
The global implantable ports market is the worldwide market for medical devices known as implantable ports or portacath. These devices are used in healthcare settings to facilitate repeated access to a patient's bloodstream for the delivery of medications, fluids, or blood products, and for blood sampling. Implantable ports consist of two main components: a reservoir or chamber that is surgically implanted beneath the skin, usually in the chest or upper arm, and a catheter that connects the reservoir to a large vein, typically the subclavian vein or jugular vein. The catheter remains inside the patient's body, providing a stable access point for medical professionals to administer treatments or perform diagnostic procedures.
Global Implantable Ports Market Dynamics
This section deals with understanding the market drivers, advantages, opportunities, restraints, and challenges. All of this is discussed in detail below:
DRIVERS
- Increasing Prevalence of Chronic Diseases
Numerous chronic diseases require long-term medication administration, often through Intravenous (IV) therapies. Implantable ports provide a convenient and reliable way to administer medications directly into the bloodstream. These ports can be accessed repeatedly, eliminating the need for frequent needle sticks and reducing patient discomfort. The growing prevalence of chronic diseases such as cancer, cardiovascular diseases, and end-stage renal diseases necessitates the use of implantable ports, thereby driving market growth.
Chronic diseases often require regular medical interventions, including repeated blood sampling, intravenous drug administration, and chemotherapy. Implantable ports offer a more convenient and efficient alternative to traditional central venous access devices. They eliminate the need for external catheters and dressing changes, allowing patients to perform their daily activities without hindrance. The use of implantable ports improves patient quality of life and satisfaction, making them a preferred choice for long-term therapy management.
- Growing Demand for Minimally Invasive Procedures
Minimally invasive procedures are associated with reduced trauma, smaller incisions, and less tissue disruption compared to traditional surgical approaches. Implantable ports, being minimally invasive devices, offer patients a more comfortable experience during the surgical implantation procedure. The smaller incisions result in less post-operative pain, shorter recovery times, and improved overall patient comfort.
Minimally invasive procedures typically require shorter hospital stays compared to traditional open surgeries. Implantable ports can be implanted on an outpatient basis or with minimal hospitalization. Patients can often go home on the same day or within a short period after the procedure, resulting in cost savings and improved resource utilization for healthcare facilities. The demand for minimally invasive options such as implantable ports aligns with the trend of reducing hospital stays and promoting ambulatory care.
OPPORTUNITY
- Rising Demand for Implantable Port Devices Due to High Success Rate
Implantable port devices have a high success rate in terms of their ability to provide reliable and long-term access to various medical treatments. The design and placement of the device ensure proper catheter function and secure attachment to the port reservoir. This makes it possible to administer drugs, administer fluids, or draw blood in a consistent and effective manner. Since patients may receive their medicines without interruptions or difficulties, the high success rate of implanted ports translates into improved treatment outcomes. The consistent access offered by implantable ports also lessens the requirement for repeated venipuncture, minimizing patient discomfort and potential consequences related to challenging venous access.
The high success rate associated with implantable port devices has increased their demand in various medical settings. Healthcare providers and patients alike recognize the advantages of these devices in terms of improved patient safety, treatment efficacy, and patient experience. The rising demand for implantable ports is driven by the desire to optimize patient outcomes and minimize the risks and complications associated with other access devices. As a result, implantable port devices have become a preferred choice for long-term intravenous therapies, contributing to their growing adoption and market demand.
RESTRAINT/CHALLENGE
- Stringent Regulatory Requirements for Approval Process
Implantable ports, such as any medical device, are subject to regulatory approval before they can be marketed and used in healthcare settings. The regulatory approval process involves extensive testing, documentation, and evaluation of the safety and efficacy of the device. This process can be lengthy and time-consuming, requiring significant financial resources and expertise. The time and cost involved in obtaining regulatory clearance or approval can delay the market entry of new implantable ports and pose barriers to smaller manufacturers or innovators who may struggle to meet these requirements.
Regulatory agencies enforce stringent safety and performance standards for implantable ports to ensure patient safety and device effectiveness. Manufacturers must demonstrate compliance with these standards through rigorous testing and clinical data. While these standards are essential for patient protection, they can increase the complexity and cost of the product development process. Meeting these requirements may involve conducting extensive preclinical and clinical studies, which can add significant time and expenses to the overall development and regulatory approval process.
Recent Developments
- In November 2022, Teleflex Incorporated announced that it had participated in the 33rd Annual Virtual Piper Sandler Healthcare Conference. This will help the organization in developing brand image among others
- In November 2021, Teleflex Incorporated announced that it was named a MedReps.com 2023 Best Place to Work, earning the Number 1 spot for large companies and making this the sixth consecutive year the company has been on the list. This will help the organization in developing brand image among others
Global Implantable Ports Market Segmentation
The global implantable ports market is segmented into four notable segments based on type, material, application, and end users. The growth among segments helps you analyze niche pockets of growth and strategies to approach the market and determine your core application areas and the difference in your target markets.
Type
- Single Lumen
- Double Lumen
- Power-Injectable
On the basis of type, the market is segmented into single lumen, double lumen, and power-injectable.
Material
- Polyurethane
- Silicone
- Titanium
- Others
On the basis of material, the market is segmented into polyurethane, silicone, titanium, and others.
Application
- Chemotherapy
- Blood Transfusion
- Antibiotics
- Intravenous Infusion of Blood Product
- Pain Management
- Others
On the basis of application, the market is segmented into chemotherapy, blood transfusion, antibiotics, intravenous infusion of blood product, pain management, and others.
End Users
- Hospitals
- Clinics
- Ambulatory Sugery Centre
- Dialysis Centers
- Others
On the basis of end users, the market is segmented into hospitals, clinics, ambulatory surgical center, dialysis centers, and others.
Global Implantable Ports Market Regional Analysis/Insights
The global implantable ports market is analyzed, and market size insights and trends are provided based on type, material, application, and end users.
The countries covered in this market report are the U.S., Canada, Mexico, Germany, France, U.K, Italy, Spain, Netherlands, Russia, Switzerland, Belgium, Turkey, rest of Europe, China, Japan, India, South Korea, Australia, Singapore, Thailand, Malaysia, Indonesia, Philippines, rest of Asia-Pacific, Brazil, Argentina, rest of South America, South Africa, Saudi Arabia, U.A.E., Egypt, Israel, and rest of Middle East and Africa.
North America is expected to dominate the global implantable ports market because of the rising awareness and government funding for implantable ports. The U.S. is expected to dominate the North America region due to the increasing strategic initiatives by major market players. Germany is expected to dominate the Europe region due to rising healthcare expenditure and the increased global presence of key market players. China is expected to dominate the Asia-Pacific region due to the growing expenses on the overall development of healthcare infrastructure.
The country section of the report also provides individual market-impacting factors and changes in market regulation that impact the current and future trends of the market. Data points such as downstream and upstream value chain analysis, technical trends, Porter's five forces analysis, and case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands and the impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.
Competitive Landscape and Global Implantable Ports Market Share Analysis
The global implantable ports market competitive landscape provides details of competitors. Details included are company overview, company financials, revenue generated, market potential, investment in R&D, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, and application dominance. The above data points provided are only related to the company’s focus on the market.
Some of the major market players operating in the global implantable ports market are B. Braun SE, AngioDynamics, BD, Teleflex Incorporated, Vygon, ICU Medical, Inc., Districlass Médical, AMI GmbH, and PakuMedmedical products gmbh among others.
SKU-